These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29948580)

  • 1. Synthesis, docking and anticancer activity of azo-linked hybrids of 1,3,4-thia-/oxadiazoles with cyclic imides.
    Bhatt P; Kumar M; Jha A
    Mol Divers; 2018 Nov; 22(4):827-840. PubMed ID: 29948580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and cytotoxicity of hybrids of 1,3,4- or 1,2,5-oxadiazoles tethered from ursane and lupane core with 1,2,3-triazole.
    Popov SA; Semenova MD; Baev DS; Frolova TS; Shestopalov MA; Wang C; Qi Z; Shults EE; Turks M
    Steroids; 2020 Oct; 162():108698. PubMed ID: 32687846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents.
    Bajaj S; Roy PP; Singh J
    Comput Biol Chem; 2018 Oct; 76():151-160. PubMed ID: 30015176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
    Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.
    El Mansouri AE; Oubella A; Maatallah M; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Med Chem Lett; 2020 Oct; 30(19):127438. PubMed ID: 32736079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cytotoxicity, and molecular docking of substituted 3-(2-methylbenzofuran-3-yl)-5-(phenoxymethyl)-1,2,4-oxadiazoles.
    Mokenapelli S; Thalari G; Vadiyaala N; Yerrabelli JR; Irlapati VK; Gorityala N; Sagurthi SR; Chitneni PR
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000006. PubMed ID: 32309890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, characterization and molecular docking studies of thiouracil derivatives as potent thymidylate synthase inhibitors and potential anticancer agents.
    El-Naggar AM; Abou-El-Regal MM; El-Metwally SA; Sherbiny FF; Eissa IH
    Mol Divers; 2017 Nov; 21(4):967-983. PubMed ID: 28815411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
    Zhang S; Luo Y; He LQ; Liu ZJ; Jiang AQ; Yang YH; Zhu HL
    Bioorg Med Chem; 2013 Jul; 21(13):3723-9. PubMed ID: 23673215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Synthesis, Anticancer Activity, Structure-Activity Relationships and Molecular Modelling Studies of Novel Isoindole-1,3(2H)-dione Compounds Containing Different Functional Groups.
    Tan A; Kizilkaya S; Kelestemur U; Akdemir A; Kara Y
    Anticancer Agents Med Chem; 2020; 20(11):1368-1378. PubMed ID: 32275494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and biological evaluation of a novel series of 1,3,4-oxadiazole bearing N-methyl-4-(trifluoromethyl)phenyl pyrazole moiety as cytotoxic agents.
    Puthiyapurayil P; Poojary B; Chikkanna C; Buridipad SK
    Eur J Med Chem; 2012 Jul; 53():203-10. PubMed ID: 22542958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-Based Drug Design: Synthesis and Biological Evaluation of Substituted Benzoin Derivatives as Potential Antitumor Agents.
    Sabbah DA; Ibrahim AH; Talib WH; Alqaisi KM; Sweidan K; Bardaweel SK; Sheikha GA; Zhong HA; Al-Shalabi E; Khalaf RA; Mubarak MS
    Med Chem; 2019; 15(4):417-429. PubMed ID: 30207238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Molecular Docking of Some Novel Thiazoles and Thiadiazoles Incorporating Pyranochromene Moiety as Potent Anticancer Agents.
    Gomha SM; Abdelhamid AO; Kandil OM; Kandeel SM; Abdelrehem NA
    Mini Rev Med Chem; 2018; 18(19):1670-1682. PubMed ID: 29692239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
    Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
    Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors.
    Sever B; Altıntop MD; Özdemir A; Akalın Çiftçi G; Ellakwa DE; Tateishi H; Radwan MO; Ibrahim MAA; Otsuka M; Fujita M; Ciftci HI; Ali TFS
    Molecules; 2020 Nov; 25(21):. PubMed ID: 33171861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.
    El Mansouri AE; Oubella A; Mehdi A; AitItto MY; Zahouily M; Morjani H; Lazrek HB
    Bioorg Chem; 2021 Mar; 108():104558. PubMed ID: 33358270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticancer evaluation of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles, 1,2,4-triazoles and Mannich bases.
    Megally Abdo NY; Kamel MM
    Chem Pharm Bull (Tokyo); 2015; 63(5):369-76. PubMed ID: 25948330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and cytotoxicity of bis-1,3,4-oxadiazoles and bis-pyrazoles derived from 1,4-bis[5-thio-4-substituted-1,2,4-triazol-3-yl]-butane and their DNA binding studies.
    Purohit M; Prasad VV; Mayur CY
    Arch Pharm (Weinheim); 2011 Apr; 344(4):248-54. PubMed ID: 21469174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation of New Oxadiazole, Thiadiazole, and Triazole Derivatives as Potential Anticancer Agents Targeting MMP-9.
    Özdemir A; Sever B; Altıntop MD; Temel HE; Atlı Ö; Baysal M; Demirci F
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28677624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Pharmacological Evalution of 1,3,4-Oxadiazole Derivatives as Collapsin Response Mediator Protein 1 (CRMP 1) Inhibitors.
    Panchal II; Rajput R; Patel AD
    Curr Drug Discov Technol; 2020; 17(1):57-67. PubMed ID: 30398117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents.
    Zhang F; Wang XL; Shi J; Wang SF; Yin Y; Yang YS; Zhang WM; Zhu HL
    Bioorg Med Chem; 2014 Jan; 22(1):468-77. PubMed ID: 24286761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.